Trial intelligence / Profile preview

MS-20 in Advanced Hepatocellular Carcinoma

NCT00707681Phase 2Unknown

Sponsor
Microbio Co., Ltd.
Start
Mar 2008
Primary completion
Dec 2010
Countries
1
01

Overview

A Phase 2 trial of MicrSoy-20 in hepatocellular carcinoma (HCC), sponsored by Microbio Co., Ltd.. Status: unknown.

02

Drugs

MicrSoy-20
03

Conditions

hepatocellular carcinoma (HCC)

Beyond the preview

Go deeper on NCT00707681.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00707681.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call